Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IncobotulinumtoxinA concentration comparison for forehead hyperhidrosis
TCTR20210825006Phase 3Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in hyperhidrosis, sponsored by Ramathibodi Hospital. Started Mar 2021; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
hyperhidrosis
Beyond the preview
Go deeper on TCTR20210825006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210825006.